Gaudium IVF and Women Health Limited is set to make history as the first dedicated fertility services provider to list on the Indian stock exchanges. The company plans to raise between **150 crore and 200 crore** through an Initial Public Offering (IPO) expected to open on **February 20, 2026**. The offering is structured as a book-built issue. It includes a fresh issue of approximately **1.14 crore equity shares** and an offer-for-sale (OFS) of nearly **95 lakh equity shares** by the promoter, Dr. Manika Khanna. The company has earmarked **50 crore** from the fresh proceeds for capital expenditure to establish **19 new IVF centers** across India. Additionally, **20 crore** will be utilized for debt repayment, while the remainder will support general corporate needs and a diversification into the FMCG sector through specialized healthcare products. Financially, the company has shown consistent growth. For the fiscal year ending March 31, 2025, Gaudium reported revenue of **70.72 crore** and a profit after tax of **19.13 crore**. This represents a sharp increase from the **47.89 crore** revenue and **10.31 crore** profit recorded in the previous year. The company currently operates a "hub-and-spoke" model with **7 hubs and 28 spokes** across multiple states. This expansion comes at a time when the Indian IVF market is projected to reach **$1.87 billion by 2029**, growing at a compound annual rate of **15.7%**. Market trends indicate that the sector is shifting from a niche service to a mainstream healthcare priority. Infertility rates in India currently stand at roughly **13%**, affecting approximately **27.5 million couples**. This demand is further fueled by delayed parenthood, lifestyle changes, and the rising adoption of advanced reproductive technologies like AI-driven embryo selection. While Gaudium is the first to launch, other major players like **Indira IVF** are also preparing for public listings, with some filings targeting a significantly higher valuation of nearly **3,500 crore**. For retail investors, the Gaudium IPO typically reserves **35%** of the net offer, with **50%** allocated to Qualified Institutional Buyers (QIBs) and **15%** for High Net-Worth Individuals (HNIs). The face value of each share is set at **5**.